ENTITY

IVERIC bio (ISEE US)

4
Analysis
Health Care • United States
IVERIC bio, Inc. operates as a biopharmaceutical company. The Company develops treatments for patients with orphan inherited retinal diseases with significant unmet medical needs. IVERIC bio serves customers in the United States.
more
Company Event • 29 Sep 2023 21:30 • Upcoming
Add To Calendar

Q1 2023

Company Event • 28 Sep 2023 21:30 • Upcoming
Add To Calendar

Q2 2023

Company Event • 01 Mar 2023 21:00 • Latest

Q4 2022

Company Event • 03 Nov 2022 21:00

Q3 2022

Company Event • 03 Aug 2022 09:40 • Upcoming
Add To Calendar

Investor Presentation

x